$NVS News and Market Events
Every $NVS story Market Flux has tracked.
- Unusual Volume
HSBC CFO Pam Kaur to Leave in 2027 as Bank Begins Successor Search
HSBC's Chief Financial Officer Pam Kaur has informed the bank's board of her intention to step down in 2027, triggering an immediate search for her replacement. Kaur, who is HSBC's first…
- Unusual Volume
Novartis Shares Crash 14% to 52-Week Low After Three Drug Trial Failures in One Week
Novartis suffered a devastating session on Tuesday, September 8, with its U.S.-listed shares tumbling roughly 14% to close at $137.70, a fresh 52-week low, after two major late-stage…
- Top Mover
Amgen Plunges 10% as Novartis Lp(a) Trial Failure Casts Doubt on Olpasiran Program
Amgen shares fell roughly 10% on Tuesday, putting the stock on course for its worst single-day decline since 2000, after Novartis reported that its Lp(a)-lowering drug pelacarsen failed in…
- Market Flux Event
Novartis and Ionis Heart Drug Pelacarsen Fails Phase 3 Trial, Sending Shares Lower
Pelacarsen, a drug developed by Novartis and partner Ionis Pharmaceuticals to lower lipoprotein(a), or Lp(a), failed to reduce the risk of cardiovascular events in a late-stage clinical…
- Unusual Volume
Novartis Jumps 6% After MS Pill Remibrutinib Succeeds in Two Phase 3 Trials, Even as CAR-T Deaths Trigger Pause
Novartis shares surged roughly 6% to approximately $161.10 on Tuesday, on track for their best single-day gain since 2023, after the company reported that remibrutinib, an oral BTK…
- Market Flux Event
Trump Announces Drug Pricing Deals With Nine More Pharma Companies, Expanding Most Favored Nation Push
President Trump announced on August 31 that his administration has struck drug pricing agreements with nine additional pharmaceutical and biotech companies, committing them to sell…